| Site Map | Webmaster | ||||
Natural Selection Inc.'s Microarray Optimization Work Referenced in Pharmaceutical Discovery
La Jolla, CA – Dr. Gary B. Fogel’s work on the use of computational intelligence to optimize microarrays has been cited in the December issue of Pharmaceutical Discovery. The article referencing Dr. Fogel, “Microarrays on the Spot: Year in Review,” highlighted the top advancements made in microarray technology in the past year. Dr. Fogel, Vice President of Natural Selection, Inc., has contributed to research in this area by studying how computational tools such as neural networks and evolutionary computation can be used to support microarray analysis in pattern recognition, particularly for class prediction and class discovery. He authored an article on the subject in the October edition of Pharmaceutical Discovery, titled, "Gene Expression Analysis Using Methods of Computational Intelligence."
Natural Selection, Inc. was founded in 1993 to address complex problems in industry, medicine, and defense. The company possesses unique expertise in computational intelligence techniques, including evolutionary computation, neural networks, and fuzzy logic. The corporation's research efforts support the discovery of new pharmaceuticals, the automated detection and discovery of important patterns and processes in bioinformatics and medical informatics, computer-assisted diagnosis, and a variety of military and industrial projects.
For more information, please contact:
Dr. Gary B. Fogel
Vice President
Natural Selection, Inc.
3333 N. Torrey Pines Ct.
Suite 200
La Jolla, CA, 92037
tel: (858) 455-6449
fax: (858) 455-1560
gfogel@natural-selection.com
and please visit our web site at http://www.natural-selection.com/.